{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-109251","form_type":"8-K/A","ticker":"CLB","cik":"0001958086","company_name":"Core Laboratories Inc. /DE/","filed_at":"2026-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.876884+00:00","generated_at":"2026-05-15T11:02:15.672812+00:00","sec_items":["2.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Core Laboratories corrects Q4/FY2025 tax error; net income down $4.2M, EPS down $0.09","bullets":["Income tax expense understated by $4.2M in Q4 and FY2025 due to tax reconciliation and fire-related insurance gain timing.","Net income reduced by $4.2M; diluted EPS reduced by $0.09 for both Q4 and full year 2025.","Revenue, operating income, and cash from operations unchanged.","Also corrected immaterial 2024 balance sheet errors: $4.7M misclassification and $5.6M write-off of unrecoverable tax receivable.","Revised financials expected in 10-K filing on or around March 17, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-109251","json":"https://secwatch.observer/filing/0001193125-26-109251.json","markdown":"https://secwatch.observer/filing/0001193125-26-109251.md","text":"https://secwatch.observer/filing/0001193125-26-109251.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526109251/0001193125-26-109251-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1958086/000119312526109251/clb-20260204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T11:02:15.672812+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}